Brazil Ophthalmic Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The brazil ophthalmic devices market size is expected to increase from USD 1.19 billion in 2025 to USD 1.25 billion in 2026 and reach USD 1.62 billion by 2030, growing at a CAGR of 5.35% over 2026-2030. This report is Segmented by Device Type (Diagnostic & Monitoring Devices (OCT Scanners, and More), Surgical Devices, and Vision Care Devices), Disease Indication (Cataract, Glaucoma, Diabetic Retinopathy, Other Disease Indications), and End-User (Hospitals, Specialty Ophthalmic Clinics, Ambulatory Surgery Centers (ASCs), Other End-Users), The Market Forecasts are Provided in Terms of Value (USD).

Brazil Ophthalmic Devices Market Trends and Insights

Aging Population Fuelling Cataract and AMD Procedure Volumes

More than 31 million Brazilians were aged 60 or older in 2021, and this cohort is projected to top 40 million by 2030. Cataract surgeries climbed to 1.18 million in 2024 after a Ministry of Health backlog-reduction fund injected R$1.2 billion, yet volumes remain below the 3,000-per-million rate the WHO recommends. Premium IOLs already account for 35% of private implants, and femtosecond laser-assisted cataract surgery accounts for 25% of São Paulo ASC cases, signaling strong upside for premium platforms. Anti-VEGF injections for AMD exceeded 1.8 million in 2025, though public facilities still rely on off-label bevacizumab due to cost differentials of up to 90%. ANVISA’s 2024 post-market-surveillance rule now covers toric and EDOF lenses, raising compliance costs but improving safety tracking.

Rising Diabetes Prevalence Driving Retinal Diagnostics and Laser Therapy

Diabetes affects 10.2% of Brazilian adults, equating to 16.6 million people, and 36.3% carry some level of diabetic retinopathy. Only 21% of diabetics were screened in 2019, leaving nearly 4.5 million undiagnosed cases that now enter AI-enabled triage streams. Phelcom’s smartphone fundus camera, cleared by ANVISA in 2023, processes images in 60 seconds and reaches 94% sensitivity, slashing referral backlogs in 120 municipalities. Private diagnostic chains installed 18% more swept-source OCT units in 2024, detecting macular edema 6 months earlier than time-domain systems and spurring demand for anti-VEGF treatment. Regulatory updates for software-as-medical-device tools require AI vendors to demonstrate AUC scores above 0.92 on Brazilian datasets, yet fast-track filings still finalize in under 180 days.

BRL Currency Volatility Inflating Import Prices

The real lost 14% against the dollar between 2023 and 2024, lifting landed prices for OCT scanners, lasers, and microscopes 12-18%. SUS cataract reimbursements have stayed flat at R$580 since 2019, squeezing hospital margins and delaying equipment replacements by up to nine months. Private ASCs increasingly opt for five-year leasing in local currency, while wholesalers without hedging saw gross-margin erosion of 300 basis points in 2024. Manaus tax exemptions offset only a small slice of exposure, as just 15% of ophthalmic SKUs are locally assembled. Retail chains passed price hikes selectively, pushing premium progressive lenses up 8-10% while keeping entry-level SKUs flat to protect volume.

Other drivers and restraints analyzed in the detailed report include:

• Technological Advances Accelerating Adoption
• SUS-Backed Tele-Ophthalmology Pilots Boosting Portable Device Uptake
• Ophthalmologist Shortage Outside Southeast Limits Device Utilization

Segment Analysis

Diagnostic and monitoring devices accounted for a modest base in 2025 but are projected to outpace every other category at an 8.52% CAGR, propelled by nationwide diabetic retinopathy mandates and AI-ready OCT systems. Vision-care goods nevertheless retained 59.77% of 2025 revenue, reflecting the country’s 71,226 optical outlets and a consumer tilt toward monthly silicone-hydrogel lenses. Contact-lens leaders Johnson & Johnson Vision and CooperVision exploit pharmacy networks to cover urban and peri-urban zones, while EssilorLuxottica leverages two domestic factories to buffer exchange-rate shocks on frames and Rx lenses.

Swept-source OCT scanners from Heidelberg Engineering and Nidek captured 60% of new premium installs last year, offering non-dye angiography that trims imaging sessions from 45 minutes to 12. Portable fundus cameras priced below USD 5,000 now feature in SUS bids across 120 municipalities, supporting 340,000 retinal images annually. Surgical devices are set to post a solid 7.9% CAGR as femtosecond laser-assisted cataract surgery penetration climbs beyond 10% nationally by 2031. The Brazil ophthalmic devices market share held by surgical consoles is likely to rise by two points by the end of the decade as private insurers reimburse outpatient cataract bundles that include premium IOLs.

Complete Report Scope:

• By Device Type
  • Diagnostic & Monitoring Devices
    • OCT Scanners
    • Fundus & Retinal Cameras
    • Autorefractors & Keratometers
    • Corneal Topography Systems
    • Ultrasound Imaging Systems
    • Perimeters & Tonometers
    • Other Diagnostic & Monitoring Devices
  • Surgical Devices
    • Cataract Surgical Devices
    • Vitreoretinal Surgical Devices
    • Refreactive Surgical Devices
    • Glaucoma Surgical Devices
    • Other Surgical Devices
  • Vision Care Devices
    • Spectacles Frames & Lenses
    • Contact Lenses
• By Disease Indication
  • Cataract
  • Glaucoma
  • Diabetic Retinopathy
  • Other Disease Indications
• By End-user
  • Hospitals
  • Specialty Ophthalmic Clinics
  • Ambulatory Surgery Centers (ASCs)
  • Other End-users

List of Companies Covered in this Report:

• Alcon
• Bausch + Lomb Corp.
• Carl Zeiss
• CooperVision Inc.
• EssilorLuxottica
• Glaukos Corp.
• Heidelberg Engineering
• Hoya Corp.
• Johnson & Johnson
• Lensar Inc.
• Lumenis
• Nidek
• Tecfen Medical
• Ziemer Group

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support